ReShape Lifesciences (RSLS) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free RSLS Stock Alerts $0.17 +0.00 (+1.19%) (As of 10:05 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineReshape Lifesciences Inc RSLSmorningstar.com - April 16 at 9:22 PMSpectral Medical (OTCMKTS:EDTXF) & ReShape Lifesciences (NASDAQ:RSLS) Head to Head Analysisamericanbankingnews.com - April 15 at 1:58 AMRSLS ReShape Lifesciences Inc.seekingalpha.com - April 7 at 6:36 PMWill GLP-1 medications replace weight loss surgery?msn.com - April 3 at 8:26 AMReShape Lifesciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - April 3 at 8:25 AMQ4 2023 ReShape Lifesciences Inc Earnings Callfinance.yahoo.com - April 2 at 11:18 AMReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Updateglobenewswire.com - April 1 at 4:05 PMLatest News for Reshape Lifesciences Stock (NASDAQ:RSLS)benzinga.com - March 29 at 7:57 PMReShape Lifesciences Inc: ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon Systemfinanznachrichten.de - March 28 at 8:29 PMReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon Systemglobenewswire.com - March 28 at 8:31 AMReShape Lifesciences sees 55.4% fall in Y/Y expenses in 2024 with cost cut planmsn.com - March 4 at 3:13 PMReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEXglobenewswire.com - March 4 at 8:31 AMReShape Lifesciences Inc (RSLS)investing.com - February 29 at 6:40 PMReShape Lifesciences, Inc.edition.cnn.com - February 29 at 7:45 AMReShape Lifesciences Inc.thestreet.com - February 24 at 9:49 AMReshape Lifesciences Stock (NASDAQ:RSLS) Insider Tradesbenzinga.com - February 22 at 9:56 AMReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEXfinance.yahoo.com - February 22 at 9:56 AMReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEXfinance.yahoo.com - February 22 at 9:56 AMReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEXglobenewswire.com - February 22 at 8:31 AMReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEXfinance.yahoo.com - January 24 at 12:53 PMReShape Lifesciences Shares Rise 5.6% on Potential Strategic Merger and Acquisition Partnership Alternativesmarketwatch.com - December 20 at 1:31 PMWhy ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarketmsn.com - December 13 at 1:24 PMWhy ReShape Lifesciences Stock Is Ripping Highermsn.com - December 13 at 1:24 PMWhy Is ReShape Lifesciences (RSLS) Stock Up 68% Today?investorplace.com - December 13 at 11:06 AMReShape Lifesciences Inc: ReShape Lifesciences Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band 2.0 FLEXfinanznachrichten.de - December 13 at 8:24 AMReShape Lifesciences spikes as FDA clears new weight loss optionmsn.com - December 13 at 8:24 AMReShape Lifesciences Gets FDA Approval for PMA Supplement Used in Latest Lap-Bandmarketwatch.com - December 12 at 8:39 PMReShape Lifesciences Shares Surge 31% After Modified Treatment Gets FDA OKmarketwatch.com - December 12 at 8:39 PMReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceedsfinance.yahoo.com - November 21 at 9:45 AMReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Planfinance.yahoo.com - November 8 at 5:33 PMA Preview Of Reshape Lifesciences's Earningsbenzinga.com - November 7 at 4:24 PMReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate Updatefinance.yahoo.com - November 6 at 12:18 PMReShape Lifesciences® Announces Pricing of $3.0 Million Public Offeringfinance.yahoo.com - September 29 at 1:56 PMReShape Lifesciences® Announces Participation in the LD Micro Main Event XVIfinance.yahoo.com - September 22 at 9:59 AMReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon Systemfinance.yahoo.com - September 19 at 9:55 AMReShape Lifesciences Inc: ReShape Lifesciences Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation Devicefinanznachrichten.de - September 14 at 1:04 PMReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ Devicefinance.yahoo.com - September 14 at 1:04 PMRSLS - ReShape Lifesciences Inc.uk.finance.yahoo.com - September 13 at 5:01 PMReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2023 Earnings Call Transcriptinsidermonkey.com - August 9 at 5:15 PMAnalysts Are Bullish on Top Healthcare Stocks: Augmedix (AUGX), ReShape Lifesciences (RSLS)markets.businessinsider.com - August 9 at 8:03 AMQ2 2023 ReShape Lifesciences Inc Earnings Callfinance.yahoo.com - August 8 at 9:57 AMReShape Lifesciences® Reports Second Quarter Ended June 30, 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 8 at 9:57 AMReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2023 and Provide Corporate Updatefinance.yahoo.com - August 3 at 5:57 PMReShape Lifesciences Inc: ReShape Lifesciences Signs Preferred Partner Agreement With Hive Medical for Lead Optimization Softwarefinanznachrichten.de - June 29 at 10:00 AMReShape Lifesciences® Signs Preferred Partner Agreement With Hive Medical for Lead Optimization Softwarefinance.yahoo.com - June 29 at 10:00 AMReShape Lifesciences® Presents Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the ASMBS 2023 Annual Meetingfinance.yahoo.com - June 28 at 9:14 AMReShape Lifesciences Inc: ReShape Lifesciences Submits FDA PMA Supplement Application for the Next-Generation Lap-Band 2.0finanznachrichten.de - June 27 at 7:41 AMReShape Lifesciences® to Participate in Investor and Industry Conferences in Junefinance.yahoo.com - June 14 at 9:19 AMQ1 2023 ReShape Lifesciences Inc Earnings Callfinance.yahoo.com - May 16 at 8:20 AMReShape Lifesciences® Reports First Quarter Ended March 31, 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - May 15 at 5:18 PM Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address The system that called 2023’s top 7 stocks is at it again… (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today. Just follow this link here! RSLS Media Mentions By Week RSLS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RSLS News Sentiment▼0.000.44▲Average Medical News Sentiment RSLS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RSLS Articles This Week▼01▲RSLS Articles Average Week Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NMRD News QNRX News BJDX News DYNT News TNON News SINT News AEMD News IONM News TMDIF News INVO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RSLS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
